Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

Zealand Pharma - Filing #1350008

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
Disclosure of non-current assets held for sale and discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Profit (loss) before tax
708,865,000 DKK
972,041,000 DKK
Revenue
342,788,000 DKK
103,986,000 DKK
Profit (loss) from discontinued operations
- DKK
236,525,000 DKK
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
425,668,000 DKK
942,311,000 DKK
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
1,094,033,000 DKK
281,259,000 DKK
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities
907,014,000 DKK
587,500,000 DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.